Dr. Carmen V Tosado, PSY. D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1212 Bulevar San Luis, Villas De Laurel I, Coto Laurel, PR 00780 Phone: 787-568-8865 |
Dr. Giovanni Alomar Sastre, PHD Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 3020 Ave San Cristobal, Coto Laurel, PR 00780 Phone: 939-835-7173 |
Laura Johanna Colon, PSY.D Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: Legacy Office Park, Suite 102, Coto Laurel, PR 00780 Phone: 787-603-0408 Fax: 787-841-5607 |
Raiza J Rodriguez Rios, PSY D. Psychologist Medicare: Medicare Enrolled Practice Location: Plaza San Cristobal, Segundo Piso, Coto Laurel, PR 00780 Phone: 787-318-8359 Fax: 787-842-4071 |
Dr. Brenda Liz Quintana Montalvo, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: Legacy Office Park Suite 102, Coto Laurel, PR 00780 Phone: 787-813-2222 Fax: 787-813-2222 |
Dr. Maria Isabel Alvarez Torrez, PSYD Psychologist - Clinical Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 41135 Paseo Turey, Carr. 511 Bo. Real Anon, Coto Laurel, PR 00780 Phone: 787-215-6571 |
Dr. Yaritza M Lopez Robledo, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 161 Calle Flamboyanes, Coto Laurel, PR 00780 Phone: 787-202-2144 |
News Archive
A systematic review from the University of Alabama at Birmingham shows that routinely opting for a repeat cesarean delivery over first attempting a vaginal delivery may result in excess morbidity and cost from a population perspective for women with a prior low transverse incision cesarean delivery who are likely to have a successful vaginal delivery.
In a world first study of its kind, 161 postnatal women with no previous depressive symptoms were divided in two separate groups to test the effect of a physiotherapist-led exercise and education program on wellbeing.
Sepracor Inc. today announced that it has received notification from the U.S. Food and Drug Administration (FDA) that the agency now anticipates completing its review of the STEDESA™ (eslicarbazepine acetate) New Drug Application (NDA) on April 30, 2010, which is a three-month extension to the original Prescription Drug User Fee Act (PDUFA) date of January 30, 2010.
The Congressional Budget Office announcement May 11, 2010, that the Patient Protection and Affordable Care Act (Obamacare) would cost, over the next ten years, $115 Billion more, brings the total cost over $1 Trillion. Imagine—Congress and the President spent a whole year jamming a 2,309 page monster down our throats on the pretense of "eliminating fraud, waste and abuse (in the delivery of medical care) at a lower cost". This same Congressional Budget Office, using the contrived numbers given by Congress, had previously said Obamacare would REDUCE federal deficits by $143 Billion. I smell FRAUD.
› Verified 9 days ago